Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ULSC in COVID-19 ARDS
NCT04494386Phase 2Completed
- Sponsor
- Restem
- Start
- Dec 2020
- Primary completion
- May 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord lining stem cells in acute respiratory distress syndrome (ARDS), sponsored by Restem. Started Dec 2020; status: completed.
02
Drugs
umbilical cord lining stem cells
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04494386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04494386.